New fixed-dose combination pills measure up to Atripla - corrected version*
Are antiretroviral switch or simplification studies of benefit for patients?
The research agenda for antiretroviral prevention – now it gets complex
Protease inhibitor monotherapy in African setting results in viral load, but not CD4, failure in the short term
Where is HIV vaccine research heading?
Imiquimod a good treatment for pre-cancerous anal lesions in men with HIV
Tenofovir microbicide halves genital herpes infections and appears safe
Microbicides can work, CAPRISA trial shows, but more trials needed before approval